ICD-9 Code 186.9
Malignant neoplasm of other and unspecified testis
Not Valid for Submission
186.9 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of other and unspecified testis. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
ICD-9: | 186.9 |
Short Description: | Malig neo testis NEC |
Long Description: | Malignant neoplasm of other and unspecified testis |
Convert 186.9 to ICD-10
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
Code Classification
-
Neoplasms (140–239)
-
Malignant neoplasm of genitourinary organs (179-189)
- 186 Malignant neoplasm of testis
-
Malignant neoplasm of genitourinary organs (179-189)
Information for Medical Professionals
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-9 Code Edits are applicable to this code:
- Diagnoses for males only Diagnoses for males only
Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to MALES only .
Synonyms
- Malignant granulosa cell tumor of testis
- Malignant Leydig cell tumor of testis
- Malignant lymphoma of testis
- Malignant sex cord tumor of testis
- Malignant teratoma of descended testis
- Malignant teratoma of testis
- Malignant tumor of testis
- Mixed seminoma teratoma of testis
- Non-seminomatous malignant neoplasm of testis
- Primary malignant neoplasm of descended testis
- Primary malignant neoplasm of testis
- Regressed malignant testicular tumor
- Seminoma
- Seminoma of descended testis
- Seminoma of testis
- Seminoma of testis, stage 1
- Seminoma of testis, stage 2
- Seminoma of testis, stage 3
- Seminoma of testis, stage 4
- T3: Testicular tumor invades spermatic cord with or without vascular/lymphatic invasion
- T4: Testicular tumor invades scrotum with or without vascular/lymphatic invasion
Index to Diseases and Injuries
References found for the code 186.9 in the Index of Diseases and Injuries:
- Androblastoma M8630 1
- malignant M8630 3
- unspecified site
- male 186.9
- unspecified site
- malignant M8630 3
- Arrhenoblastoma M8630 1
- malignant M8630 3
- unspecified site
- male 186.9
- unspecified site
- malignant M8630 3
- Carcinoma M8010 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- chorionic M9100 3
- unspecified site
- male 186.9
- unspecified site
- Leydig cell testis M8650 3
- unspecified site 186.9
- female 183.0
- male 186.9
- unspecified site 186.9
- Sertoli cell M8640 3
- unspecified site 186.9
- chorionic M9100 3
- Choriocarcinoma M9100 3
- unspecified site
- male 186.9
- unspecified site
- Dysgerminoma M9060 3
- unspecified site
- male 186.9
- unspecified site
- Embryoma M9080 1 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site uncertain behavior- malignant M9080 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- testis M9070 3 186.9
- undescended 186.0
- testis M9070 3 186.9
- testis M9070 3 186.9
- undescended 186.0
- malignant M9080 3 SEE ALSO See Also
- Leydig cell
- carcinoma M8650 3
- unspecified site
- male 186.9
- unspecified site
- tumor M8650 1
- malignant M8650 3
- unspecified site
- male 186.9
- unspecified site
- malignant M8650 3
- carcinoma M8650 3
- Live flesh 781.0
- nbsp
- testis testes descended scrotal 186.9 198.82 233.6 222.0 236.4 239.5
- ectopic 186.0 198.82 233.6 222.0 236.4 239.5
- retained 186.0 198.82 233.6 222.0 236.4 239.5
- undescended 186.0 198.82 233.6 222.0 236.4 239.5
- testis testes descended scrotal 186.9 198.82 233.6 222.0 236.4 239.5
- Orchioblastoma M9071 3 186.9
- Seminoma M9061 3
- anaplastic type M9062 3
- unspecified site 186.9
- spermatocytic M9063 3
- unspecified site 186.9
- unspecified site 186.9
- anaplastic type M9062 3
- Sertoli cell
- carcinoma M8640 3
- unspecified site 186.9
- carcinoma M8640 3
- Spermatocytoma M9063 3
- unspecified site 186.9
- Teratoma solid M9080 1 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site uncertain behavior- malignant M9080 3 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site malignant- trophoblastic M9102 3
- unspecified site 186.9
- trophoblastic M9102 3
- testis M9080 3 186.9
- adult benign cystic differentiated type or mature M9080 0 222.0
- undescended 186.0
- malignant M9080 3 SEE ALSO See Also
- Tumor M8000 1 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm by site unspecified nature- endodermal sinus M9071 3
- unspecified site
- male 186.9
- unspecified site
- Leydig cell M8650 1
- malignant M8650 3
- unspecified site
- male 186.9
- unspecified site
- malignant M8650 3
- polyvesicular vitelline M9071 3
- unspecified site
- male 186.9
- unspecified site
- yolk sac M9071 3
- unspecified site
- male 186.9
- unspecified site
- endodermal sinus M9071 3
Information for Patients
Testicular Cancer
Testicles, or testes, make male hormones and sperm. They are two egg-shaped organs inside the scrotum, the loose sac of skin behind the penis. You can get cancer in one or both testicles.
Testicular cancer mainly affects young men between the ages of 20 and 39. It is also more common in men who:
- Have had abnormal testicle development
- Have had an undescended testicle
- Have a family history of the cancer
Symptoms include pain, swelling, or lumps in your testicles or groin area. Doctors use a physical exam, lab tests, imaging tests, and a biopsy to diagnose testicular cancer. Most cases can be treated, especially if found early. Treatment options include surgery, radiation, and/or chemotherapy. Regular exams after treatment are important.
Treatments may also cause infertility. If you may want children later on, you should consider sperm banking before treatment.
NIH: National Cancer Institute
[Read More]
ICD-9 Footnotes
General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Index of Diseases and Injuries Definitions
- And - The word "and" should be interpreted to mean either "and" or "or" when it appears in a title.
- Code also note - A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- Code first - Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- Type 2 Excludes Notes - A type 2 Excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- Includes Notes - This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- Inclusion terms - List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
- NOS "Not otherwise specified" - This abbreviation is the equivalent of unspecified.
- See - The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code.
- See Also - A "see also" instruction following a main term in the Alphabetic Index instructs that there is another main term that may also be referenced that may provide additional Alphabetic Index entries that may be useful. It is not necessary to follow the "see also" note when the original main term provides the necessary code.
- 7th Characters - Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- With - The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order.